CRP and cancer: Previous studies [12–14] have examined the prognostic significance of inflammatory response markers, including neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP)-to-albumin ratio (CAR), platelet-to-lymphocyte ratio (PLR), and albumin-to-globulin ratio (AGR), for various cancers.